Inventor
LINDA LIANG
Inventor
US
Overview
Patents· 11 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes26%
C07KPeptides26%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
G01NInvestigating or analysing materials by determining their chemical or physical properties12%
Y02ATechnologies for adaptation to climate change12%
PatentTitleYear
12,435,136Antibodies binding to ILT4202512,378,311Anti-MARCO antibodies and uses thereof202512,102,680Anti-TIGIT antibodies202412,102,681Anti-LAG3 antibodies and antigen-binding fragments202412,065,491Anti-TREM1 antibodies and related methods202411,958,902Anti-TIGIT antibodies202411,572,407Anti-MARCO antibodies and uses thereof202311,510,993Antibody drug conjugate for anti-inflammatory applications202211,401,328Antibodies binding to ILT4202211,278,620Anti-LAG3 antibodies and antigen-binding fragments202211,207,406Anti-LAG3 antibodies and antigen-binding fragments2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2022Patents assigned to MERCK SHARP & DOHME (3)· patent assignee history
2021–2025Based in US· patent location history
2022–2024Patents assigned to MERCK SHARP & DOHME LLC (4)· patent assignee history
2022–2025Patents assigned to BRISTOL MYERS SQUIBB CO (2)· patent assignee history
2022–2025Patents assigned to FIVE PRIME THERAPEUTICS INC (2)· patent assignee history
2023–2024Patents assigned to PIONYR IMMUNOTHERAPEUTICS INC (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MERCK SHARP & DOHME LLC | 4 | 2022–2024 |
| MERCK SHARP & DOHME | 3 | 2021–2022 |
| BRISTOL MYERS SQUIBB CO | 2 | 2022–2025 |
| FIVE PRIME THERAPEUTICS INC | 2 | 2022–2025 |
| PIONYR IMMUNOTHERAPEUTICS INC | 2 | 2023–2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 11 | 2021–2025 |